About
Samuel Hall is a founder and Managing Partner of Scion, with over 20 years of experience in life sciences as an investor, scientist and entrepreneur. From 2013 to 2019 he was a Partner at Apple Tree Partners, where he helped form and build therapeutics companies, and earlier worked as an immunologist at the University of Cambridge, an investment team member at Symphony Capital, and a healthcare investment banker at Citigroup. He holds an A.B. in Molecular Biology from Princeton University and completed his M.Phil. and Ph.D. at the University of Cambridge.
Invests in
Biotech
Experience
- Scion Life SciencesCo-Founder & Managing Partnercurrent2020 — presentNew York
- Stoke TherapeuticsDirector2015 — 2020
- Chinook Therapeutics, Inc.Director2019
- Ascidian TherapeuticsDirector2016 — 2019
- Marengo TherapeuticsDirector2015 — 2019
- Apple Tree PartnersPartner2013 — 2019Greater New York City Area
- SyntimmuneDirector2014 — 2018
- University of CambridgeImmunologist2009 — 2013
- Symphony CapitalAssociate2005 — 2008
- CitigroupFinancial Analyst2003 — 2005
Education
- Princeton UniversityA.B., Molecular Biology
- University of CambridgeMPhil, Institute of Biotechnology
- University of CambridgePhD, Immunology
Skills & more
+12 more
EquitiesMergers & AcquisitionsDue DiligenceLife SciencesDrug DevelopmentDrug DiscoveryLifesciencesEntrepreneurshipImmunologyMedical DevicesBiopharmaceuticalsStart-upsFrom Samuel's professional profile.
Same school
Also attended Princeton University474
.jpg)
.png)
+ 468 more
Also attended University of Cambridge652
.png)
+ 646 more
Shared employers
Also worked at Stoke Therapeutics2
Also worked at Ascidian Therapeutics1
Also worked at Apple Tree Partners7
+ 1 more
Also worked at University of Cambridge107
.webp)
+ 101 more
Investments
Board seats
Ascidian TherapeuticsChinook TherapeuticsMarengo TherapeuticsStoke TherapeuticsSyntimmune
Per the firm's website.
